Physician profile
William Perucki
NPI 1346669967
$37,246.96
in general payments reported to CMS, 2019-2025
29 companies · $916 in 2025
The $916 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,600 · 2020: $466 · 2021: $23K · 2022: $2,813 · 2023: $5,315 · 2024: $1,718 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,887 · Grant: $1,500 · Travel and Lodging: $876 · Consulting Fee: $475 · Education: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,886.90 |
| Grant | $1,500.00 |
| Travel and Lodging | $876.09 |
| Consulting Fee | $475.00 |
| Education | $211.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25,425.46 | 2021-2025 | Micra, Linq II, Mycarelink |
| Abbott Laboratories | $4,850.63 | 2021-2024 | Jot Dx, Ensite, Aveir |
| Boston Scientific Corporation | $2,128.30 | 2022-2023 | |
| Medtronic Vascular, INC. | $1,386.89 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $565.53 | 2019-2025 | Farxiga, Wainua |
| Biosense Webster, INC. | $444.52 | 2024-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $295.14 | 2019-2021 | |
| Astellas Pharma US INC | $198.99 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.04 | 2019-2025 | Jardiance |
| Pfizer INC. | $192.64 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.97 | 2019-2025 | |
| Amgen INC. | $136.99 | 2020-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $135.44 | 2019 | |
| Merck Sharp & Dohme LLC | $130.48 | 2023-2025 | Verquvo |
| Esperion Therapeutics, INC. | $130.23 | 2024-2025 | Nexletol |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $112.08 | 2019-2025 | Camzyos |
| Bridgebio Pharma, INC. | $105.07 | 2025 | Attruby |
| Abiomed | $93.68 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $84.88 | 2023-2025 | |
| Bardy Diagnostics, INC. | $82.46 | 2020 | |
| Novo Nordisk INC | $62.74 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $38.16 | 2023-2025 | Amvuttra, Onpattro |
| Janssen Pharmaceuticals, INC | $35.98 | 2023-2024 | Xarelto |
| Medicomp INC | $30.13 | 2024 | Telepatch Cardiac Monitor |
| Atricure, INC. | $29.63 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $26.74 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $26.72 | 2024 | |
| Lantheus Medical Imaging, INC. | $15.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Perucki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.